High Flow Nasal Cannula
Devicehumidified and heated oxygen
NCT Number: NCT06489379
The aim of this multicenter, randomized, controlled, open-label trial is to investigate the efficacy of early treatment with HFNO compared with SOT in preventing early deterioration of patients admitted to the ER because of acute hypoxemic respiratory failure.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
humidified and heated oxygen
oxygen delivery through Venturi mask
Time frame: 24 hours
occurrence of any of the following from randomization: respiratory worsening; respiratory acidosis; severe respiratory distress; start of non-invasive ventilation; necessity of endotracheal intubation; development of shock; death.
Time frame: 2, 12 and 24 hours
arterial pH
Time frame: 2, 12 and 24 hours
arterial pCO2
Time frame: 2, 12 and 24 hours
P/F ratio
Time frame: 2, 12 and 24 hours
respiratory frequency
Time frame: 90 days
hours of ventilatory support
Time frame: 90 days
number of patients admitted to ICU
Time frame: 30 days
duration of hospitalization
Time frame: 90 days
death during hospitalization
Time frame: 90 days
duration of ICU stay
Time frame: 90 days
death in ICU
Time frame: 90 days
composite outcome of septic shock, nosocomial pneumonia, cardiac arrhythmia, cardiac arrest, delirium
Time frame: 24 hours
utilizing Borg scale
Time frame: 24 hours
utilizing visual analogue scale
Time frame: 24 hours
type of ward admission
Time frame: 24 hours
rate of early deterioration in the treatment group will be compared between patients treated with standard or asymmetrical high-flow nasal cannula
Contact information is provided by the study sponsor or research team.
Francesco Franceschi, MD
CONTACT
Gianluca Tullo, MD
CONTACT
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Other
High Flow Nasal Oxygen for Acute Hypoxemic Respiratory Failure in the Emergency Room: the GLAMOUR Study
Acronym: GLAMOUR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04582201
Lung Diseases, Respiration Disorders
Santa Monica, California, United States
View Trial DetailsNCT03818854
Lung Diseases, Respiration Disorders
Sacramento, California, United States
View Trial DetailsNCT02273687
Disease Attributes, Emergencies
Nîmes, France
View Trial DetailsNCT01743105
Disease Attributes, Emergencies
Nîmes, Gard, France
View Trial Details